Growing community of inventors

San Diego, CA, United States of America

Shahram Salek-Ardakani

Average Co-Inventor Count = 2.23

ph-index = 7

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 178

Shahram Salek-ArdakaniMichael Croft (9 patents)Shahram Salek-ArdakaniAlessandro D Sette (1 patent)Shahram Salek-ArdakaniCarl F Ware (1 patent)Shahram Salek-ArdakaniMagdalini Moutaftsi (1 patent)Shahram Salek-ArdakaniTaylor Doherty (1 patent)Shahram Salek-ArdakaniShahram Salek-Ardakani (9 patents)Michael CroftMichael Croft (15 patents)Alessandro D SetteAlessandro D Sette (42 patents)Carl F WareCarl F Ware (19 patents)Magdalini MoutaftsiMagdalini Moutaftsi (1 patent)Taylor DohertyTaylor Doherty (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. La Jolla Institute for Allergy and Immunology (9 from 59 patents)


9 patents:

1. 10106619 - Virus vaccination and treatment methods with OX40 agonist compositions

2. 9873744 - Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same

3. 9301994 - LIGHT inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment

4. 8956615 - Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same

5. 8551477 - Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same

6. 8101175 - Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same

7. 7807156 - Methods of treating OX40 mediated recall immune responses

8. 7531170 - Methods of treating OX40 mediated recall immune responses and agents useful for identifying same

9. 7291331 - Methods of treating OX40 medicated recall immune responses

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…